1014PDPhase I/II, first in human trial with M7583, a Bruton’s tyrosine kinase inhibitor (BTKi), in patients with B cell malignanciesW Jurczak,S Rule,W Townsend,D Tucker,B Sarholz,J Scheele,J Gribben,P L ZinzaniANNALS OF ONCOLOGY(2018)引用 1|浏览41暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要